Condensed Statement of Cash Flows (Unaudited)	3 Months Ended
	Mar. 31, 2021 USD ($)
Cash Flows from Operating Activities:
Net income	$ 2,546,530
Adjustments to reconcile net income to net cash used in operating activities:
Change in fair value of warrant liabilities	(3,210,000)
Interest earned on marketable securities held in Trust Account	(3,907)
Transaction costs incurred in connection with IPO	520,319
Changes in operating assets and liabilities:
Prepaid expenses	(798,779)
Accounts payable and accrued expenses	81,118
Net cash used in operating activities	(864,719)
Cash Flows from Investing Activities:
Investment of cash in Trust Account	(230,000,000)
Net cash used in investing activities	(230,000,000)
Cash Flows from Financing Activities:
Proceeds from sale of Units, net of underwriting discounts paid	226,000,000
Proceeds from sale of Private Warrants	6,000,000
Proceeds from promissory note – related party	60,910
Over payment of promissory note	(25,000)
Repayment of advances from related party	(130,410)
Payment of offering costs	(364,217)
Net cash provided by financing activities	231,541,283
Net Change in Cash	676,564
Cash – Beginning of period
Cash – End of period	676,564
Non-cash investing and financing activities:
Offering costs included in accrued offering costs	10,532
Initial classification of ordinary shares subject to possible redemption	204,195,750
Change in value of ordinary shares subject to possible redemption	3,066,847
Deferred underwriting commission payable	$ 8,650,000